Among the new aPL that have been described associated with APS-events, the IgA aB2GP1 and the anti-phosphatidyl serine/prothrombin (IgG or IgM) are those where a greater association with the APS clinical aspects has been observed (11–13). The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.